906101-33-5 Usage
Uses
Used in Food Industry:
4'-tert-Butyl-2,6-dimethylbiphenyl-4-ol is used as an antioxidant for [application reason] to prevent oxidation and extend the shelf life of food products. It acts as a stabilizer, protecting food items from rancidity and deterioration caused by exposure to oxygen and light.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 4'-tert-Butyl-2,6-dimethylbiphenyl-4-ol is used as a preservative for [application reason] to maintain the stability and potency of medications, ensuring their effectiveness over time by preventing oxidation.
Used in Cosmetics Industry:
4'-tert-Butyl-2,6-dimethylbiphenyl-4-ol is utilized as an antioxidant in cosmetics for [application reason] to protect the integrity of cosmetic products, enhancing their shelf life and performance by inhibiting oxidation processes that could lead to product degradation.
While BHT-4-ol is considered safe for use in small amounts, there has been some debate over its potential health effects and environmental impact. As a result, regulatory agencies are closely monitoring its use to ensure safety and compliance with established guidelines.
Check Digit Verification of cas no
The CAS Registry Mumber 906101-33-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,6,1,0 and 1 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 906101-33:
(8*9)+(7*0)+(6*6)+(5*1)+(4*0)+(3*1)+(2*3)+(1*3)=125
125 % 10 = 5
So 906101-33-5 is a valid CAS Registry Number.
InChI:InChI=1/C18H22O/c1-12-10-16(19)11-13(2)17(12)14-6-8-15(9-7-14)18(3,4)5/h6-11,19H,1-5H3
906101-33-5Relevant academic research and scientific papers
GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES
-
Page/Page column 14, (2009/07/03)
The present invention discloses novel compounds of Formula (I), or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the
GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES
-
Page/Page column 30, (2008/06/13)
The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the in
